Adocia Stock

Adocia FCF per Share

The Free Cash Flow per Share of Adocia (ADOC.PA) as of Aug 12, 2026 is -0.35 EUR. In the previous year, Free Cash Flow per Share was -1.02 EUR — a change of -66.14% (higher).

FCF per Share

-0.35EUR

YoY

-66.14%

Last updated:

Free Cash Flow per Share of Adocia is 2026 -0.35 EUR. Free Cash Flow per Share of Adocia was 2025 -1.02 EUR. It decreases by -66.14% higher compared to the previous year.
Access this data via the Eulerpool API

Adocia Stock analysis

What does Adocia do? Adocia SA is a French biotechnology company specializing in the development of innovative therapies for diabetes and other serious diseases. The company was founded in 2005 by a team of experienced scientists and entrepreneurs and has its headquarters in Lyon, France, with a branch office in Boston, USA. Adocia's activities are focused on three main areas: insulins, GLP-1 analogs, and biosimilars. The company develops various products in these areas that are known for their effectiveness and safety. Adocia's success is based on a combination of innovative technologies, experienced leadership, and strategic partnerships that allow the company to adapt quickly to market changes and take advantage of growth potential. Adocia is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Adocia stock

Free Cash Flow per Share of Adocia is -0.35 EUR in 2026.

Free Cash Flow per Share of Adocia changed from -1.02 EUR to -0.35 EUR, representing a -66.14% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share Adocia since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

Cash Flow — Adocia

All Key Metrics — Adocia